News | December 04, 2025
Philips unveils helium-free 3.0T MRI innovation at RSNA 2025
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
Grant of Permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole capsule (375mg/500mg + 20mg/20mg)
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
Patients can now get the starting 2.5 mg dose for $299 per month
The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
The audit was completed with zero critical and zero major observations
The 7,000th store was inaugurated in Ayodhya, Uttar Pradesh
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
Clinical studies conducted in India demonstrated that this nebulized triple therapy rapidly improves lung function and offers better control of breathlessness
Subscribe To Our Newsletter & Stay Updated
